Atópiás dermatitisz (ekcéma): vizsgálatok itt: Dél-Korea
5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Where
- Ansan-si, Gwangju, Seoul
- Életkor
- 6 hónap to 11 év
- People
- 195 worldwide
- Run by
- LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00 - 2. fázisTaking peoplePlatform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Ansan, Seoul
- Életkor
- 18 év to 100 év
- People
- 224 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
- Where
- Ansan
- Életkor
- 19 év and over
- People
- 162
- Run by
- HK inno.N Corporation
See details and how to joinNCT07073677 - No phaseTaking peopleA Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
- Where
- Seoul
- Életkor
- 12 év and over
- People
- 1100
- Run by
- Pfizer
See details and how to joinNCT05391061 - No phaseNot yet taking people in Dél-KoreaLong-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
- Where
- Ilsan
- Életkor
- 19 év and over
- People
- 102
- Run by
- Kang Stem Biotech Co., Ltd.
See details and how to joinNCT04730024